Premier Heart, LLC just announced the formation of Premier Heart CICA, a new division to launch its Multifunction Cardio Gram? (MCG) system in Latin America and the Caribbean. Based in Miami, Florida, Premier Heart CICA is responsible for marketing and distributing MCG technology.Premier Heart, LLC, a privately held New York based company, launched the groundbreaking technology, MCG, in the United States in July, 2009 following 15 years of research and development. MCG is the world’s first Internet-based, non-invasive, stress, radiation and drug-free computational electrophysiological system used for interactive online diagnosis of heart disease.“I believe that the MCG represents a major advance in the diagnosis and management of coronary artery disease. It provides a means of identifying significant disease much earlier, and does so with greater patient accessibility and far less expensively than conventional methodologies. These factors are particularly relevant in Caribbean countries where optimal use of financial resources is so crucial,” stated Norbert W. Rainford, MD, FACC, Asst. Professor of Medicine, Center for Interventional Vascular Therapy, Columbia University, NY and former Medical Director, Empire Medicare Services, NY.Cardiovascular Disease is responsible for 35% of deaths in the Caribbean and Latin America. Ischemic heart disease is the leading cause of death worldwide, accounting for more than 25% of all deaths in Latin America.“By using MCG technology medical professionals will be able to offer a cost effective method for early detection of heart disease. Earlier and more accurate detection is key to preventing advanced heart disease and premature deaths…” said Joseph Shen, M.D., founder and co-developer of MCG technology. Dr. Shen added, “Because of its fundamentally unconventional mathematical approach, MCG represents a paradigm shift in heart disease diagnosis. Its ease of use and better accuracy will save lives and bring much needed cost-savings to the world’s cardiovascular healthcare markets.“Premier Heart CICA offers the MCG system in two affordable models: a portable device for physician offices and a medical pushcart for institutional users. Both are offered in multiple languages including English and Spanish.
Premier Heart, LLC, a privately held New York based company, launched the groundbreaking technology, MCG, in the United States in July, 2009 following 15 years of research and development. MCG is the world’s first Internet-based, non-invasive, stress, radiation and drug-free computational electrophysiological system used for interactive online diagnosis of heart disease.
“I believe that the MCG represents a major advance in the diagnosis and management of coronary artery disease. It provides a means of identifying significant disease much earlier, and does so with greater patient accessibility and far less expensively than conventional methodologies. These factors are particularly relevant in Caribbean countries where optimal use of financial resources is so crucial,” stated Norbert W. Rainford, MD, FACC, Asst. Professor of Medicine, Center for Interventional Vascular Therapy, Columbia University, NY and former Medical Director, Empire Medicare Services, NY.Cardiovascular Disease is responsible for 35% of deaths in the Caribbean and Latin America. Ischemic heart disease is the leading cause of death worldwide, accounting for more than 25% of all deaths in Latin America.“By using MCG technology medical professionals will be able to offer a cost effective method for early detection of heart disease. Earlier and more accurate detection is key to preventing advanced heart disease and premature deaths…” said Joseph Shen, M.D., founder and co-developer of MCG technology.
Dr. Shen added, “Because of its fundamentally unconventional mathematical approach, MCG represents a paradigm shift in heart disease diagnosis. Its ease of use and better accuracy will save lives and bring much needed cost-savings to the world’s cardiovascular healthcare markets.“Premier Heart CICA offers the MCG system in two affordable models: a portable device for physician offices and a medical pushcart for institutional users. Both are offered in multiple languages including English and Spanish.
Leave a Reply